Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT00813982 Completed - Myopia Clinical Trials

Daily Wear Comparison of Enhanced and Non-Enhanced Silicone Hydrogel Lenses

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare an experimental contact lens with a currently marketed contact lens.

NCT ID: NCT00813761 Completed - Myopia Clinical Trials

Clinical Evaluation of the Long‑Term Effects of Contact Lens Care Systems

Start date: September 1, 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two marketed contact lens care solutions in regards to comfort and ocular health.

NCT ID: NCT00810511 Completed - Myopia Clinical Trials

Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this trial is to compare two different contact lenses during 4 weeks of wear.

NCT ID: NCT00808834 Completed - Myopia Clinical Trials

Non-dispense Comfort Comparison of Two Silicone Hydrogel Lenses

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare subjective responses to two contact lenses after 15 minutes of wear.

NCT ID: NCT00802126 Completed - Myopia Clinical Trials

Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy

Start date: November 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to report the treatment effect and safety of combined intravitreal bevacizumab (IVB) and photodynamic therapy (PDT) with verteporfin using a reduced (RF) light fluence rate, in choroidal neovascularization (CNV) secondary to pathologic myopia.

NCT ID: NCT00797992 Completed - Clinical trials for Myopic Choroidal Neovascularization

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

Start date: January 2007
Phase: Phase 4
Study type: Interventional

To evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary to pathologic myopia (PM-CNV).

NCT ID: NCT00787579 Completed - Myopia Clinical Trials

Assessment of Bifocal and Prismatic Bifocal Spectacles for Myopia Control in Children

Start date: April 2003
Phase: N/A
Study type: Interventional

1. To determine if the effect of near-addition lenses (bifocals) is more prominent for children with high myopia progression. 2. To study how different subject characteristics such as age, gender, baseline degree of myopia, baseline near phoria and baseline lag of accommodation affect the efficacy of bifocal lens wear in myopic children. 3. To investigate the effect of incorporating near base-in prisms along with the near-addition lenses (prismatic bifocals) on myopia progression in myopic children.

NCT ID: NCT00784641 Completed - Myopia Clinical Trials

A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use

Start date: November 2008
Phase: N/A
Study type: Interventional

Evaluation of the clinical performance of a novel Bausch & Lomb daily disposable contact lens when compared to the currently marketed Bausch & Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft contact lens wearers on a daily disposable basis.

NCT ID: NCT00775021 Completed - Myopia Clinical Trials

A Clinical Comparison of Two Daily Disposable Contact Lenses.

Start date: August 2008
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.

NCT ID: NCT00772707 Completed - Myopia Clinical Trials

A Multi‐Center Investigation of Patient Acceptability of OPTI‐FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)

Start date: September 2008
Phase: N/A
Study type: Interventional

The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.